|Articles|January 21, 2021
Operational Impact of Annex 1 Update
Author(s)Veltek Associates, Inc.
The update for EU annex 1 is more than a simple revision, solidifying the expectation that facility fully understand their processes and systems.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Implications on SMA Care of High-Dose Nusinersen
2
Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation
3
How Therapeutic and Analytical Advancements Help Drug Substance Testing Evolve
4
ADA Assays for Complex Molecule Development
5
